Eris Lifesciences acquires Oaknet Healthcare

04 May 2022 Evaluate

Eris Lifesciences has acquired Mumbai-based dermatology-focused domestic formulations company Oaknet Healthcare for Rs 650 crore. The acquisition will be completed by way of a share purchase agreement and accordingly Oaknet will become a wholly-owned subsidiary of Eris. The deal will be financed by Rs 300 crore internal accruals and Rs 350 crore by borrowings.

Eris Lifesciences is the only publicly listed Indian pharmaceutical company with a pure-play domestic branded formulations business model.

Eris Lifesciences Share Price

1386.30 -31.40 (-2.21%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×